Frequently Asked Questions
The market for Cancer Biomarkers Market is expected to reach USD 30,284.5 Mn By 2025.
The Cancer Biomarkers Market is expected to see significant CAGR growth over the coming years, at 11.5%.
The report is forecasted from 2017-2025.
The base year of this report is 2016.
Affymetrix, Inc., DiagnoCure, Inc., Qiagen NV, Illumina, Inc., Roche Diagnostics Ltd., Quest Diagnostics Inc., Agilent Technologies, Inc., Merck & Co., Inc., Hologic, Inc. are some of the major players in the global market.